About: http://data.cimple.eu/news-article/2a042e0a6b2af6862298188ea681e29c6908d94474f3c70a3540a74f

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/2a042e0a6b2af6862298188ea681e29c6908d94474f3c70a3540a74f Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	South African President Cyril Ramaphosa on Wednesday welcomed the World Health Organisation's approval of Sinovac Covid-19 vaccine for emergency use, hoping it will mean more vaccines for his population and those in poorer countries. The emergency approval for the Beijing-based firm Sinovac's two-dose vaccine CoronaVac, announced Tuesday, opens the door for the jabs to be included in the Covax global vaccine-sharing facility, which aims to provide equitable access to doses around the world, particularly in poorer countries. "We welcome the news that the World Health Organisation has validated the Sinovac from China covid-19 vaccine for emergency use," Ramaphosa told parliament in Cape Town. Ramaphosa lauded the go-ahead as "a crucial step" that should move South Africa's regulatory authorities to look into purchasing Sinovac. The Sinovac serum is "easy to store" and therefore "easy to manage, and particularly suitable for countries with few resources", said WHO. With over 1.6 million cases of which 56,601 were fatalities, around 1,045,104 people in South Africa have so far received jabs, mainly the elderly --who are yet to receive a second jab -- and healthcare workers, using the Pfizer and Johnson & Johnson vaccines. Ramaphosa said the government, which has been widely criticised for a slow vaccination drive, is continuing to engage with various manufacturers to ensure a reliable and diverse supply of vaccines. But he stressed, once again, the need to waive intellectual property rights over coronavirus jabs, arguing it would speed up vaccine distribution and boost the local pharmaceutical market. "It will pave the way for the development and growth of local pharmaceutical industries in our own country, on the continent as well and in other developing countries." The global campaign championed by South Africa and India to temporarily waive intellectual property rights for Covid vaccines was supported by the other BRICS countries -- Brazil, Russia, China -- at this week's meeting of five of the world's biggest emerging economies held in Delhi. mgu/har
schema:headline	South Africa hails WHO approval of Chinese Sinovac jab
schema:mentions	Intellectual property Developing country Cape Town Cyril Ramaphosa Pharmaceutical industry Johnson & Johnson New Delhi Sinovac Biotech Jab President of Russia World Health Organization South Africa Russia Pfizer India Coronavirus disease Brazil Vaccine China Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 BRIC
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-06-02 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	88 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software